MedTrace Logo

Transition in Transgender

NCT04736797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-02-12

No results posted yet for this study

Summary

The aim of this longitudinal, observational study is to investigate the effects of gender-affirming hormone treatment in FTM (female to male) and MTF (male to female) transgender (TG) people with regard to changes in brain structure and function as well as psychological and behavioral consequences. Methodological problems and missing studies in this area were mentioned several times with an emphasis on the need for longitudinal research.

Conditions

  • Gender Dysphoria

Sponsors & Collaborators

  • University Hospital Tuebingen

    collaborator OTHER

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Ute Habel, Prof. Dr. · Uniklinkum Aachen

  • Birgit Derntl, Prof. Dr. · Uniklinikum Tübingen

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-27
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04736797 on ClinicalTrials.gov